title: Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.
authors: Niklas
authors: N
authors: Schaefer
authors: Katja
authors: K
authors: Rasch
authors: Markus
authors: M
authors: Moehlenbruch
authors: Horst
authors: H
authors: Urbach
authors: Moritz
authors: M
authors: Stuplich
authors: Elias
authors: E
authors: Blasius
authors: Bjoern
authors: B
authors: Scheffler
authors: Ulrich
authors: U
authors: Herrlinger
authors: Martin
authors: M
authors: Glas
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D007278:Injections, Spinal; D008081:Liposomes / Q000008:administration & dosage; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000532:radiotherapy*; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008875:Middle Aged; D000077204:Temozolomide
chemical_list: D008081:Liposomes; D003561:Cytarabine; D003606:Dacarbazine; D000077204:Temozolomide